title: CD56 and terminal deoxynucleotidyl transferase positive cutaneous lymphoblastic lymphoma.
authors.forename: Y
authors.initials: Y
authors.lastname: Amo
authors.forename: K
authors.initials: K
authors.lastname: Yonemoto
authors.forename: T
authors.initials: T
authors.lastname: Ohkawa
authors.forename: M
authors.initials: M
authors.lastname: Sasaki
authors.forename: Y
authors.initials: Y
authors.lastname: Isobe
authors.forename: K
authors.initials: K
authors.lastname: Sugimoto
authors.forename: K
authors.initials: K
authors.lastname: Katsuoka
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019002:CD56 Antigen / Q000276:immunology*; D004253:DNA Nucleotidylexotransferase / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D019002:CD56 Antigen; D004253:DNA Nucleotidylexotransferase